Amazentis
Lausanne, CH · 2 known investors
Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy. It brings the molecule to consumers through its Timeline brand of supplements and skincare, and partners with companies including Nestlé Health Science and L'Oréal.
Investors · 2
Frequently asked questions
- What does Amazentis do?
- Amazentis is a Swiss longevity-biotech company that developed Mitopure, a proprietary high-purity form of the postbiotic Urolithin A shown in human trials to support mitochondrial health via mitophagy. It brings the molecule to consumers through its Timeline brand of supplements and skincare, and partners with companies including Nestlé Health Science and L'Oréal.
- Who are Amazentis's investors?
- Amazentis's investors include Bold Capital Partners, +ND Capital.
- Where is Amazentis headquartered?
- Amazentis is headquartered in Lausanne, CH.